GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $67,000 | 0.0% | 1,529 | 0.0% | 0.03% | +21.7% |
| Q1 2022 | $67,000 | +1.5% | 1,529 | +1.8% | 0.02% | 0.0% |
| Q4 2021 | $66,000 | +10.0% | 1,502 | -4.3% | 0.02% | -4.2% |
| Q3 2021 | $60,000 | -4.8% | 1,570 | 0.0% | 0.02% | -17.2% |
| Q2 2021 | $63,000 | +12.5% | 1,570 | 0.0% | 0.03% | +7.4% |
| Q1 2021 | $56,000 | +60.0% | 1,570 | +63.4% | 0.03% | +22.7% |
| Q4 2020 | $35,000 | -2.8% | 961 | 0.0% | 0.02% | -12.0% |
| Q3 2020 | $36,000 | -59.1% | 961 | -55.6% | 0.02% | -61.5% |
| Q2 2020 | $88,000 | +175.0% | 2,166 | +157.9% | 0.06% | +140.7% |
| Q1 2020 | $32,000 | -17.9% | 840 | 0.0% | 0.03% | 0.0% |
| Q4 2019 | $39,000 | +8.3% | 840 | 0.0% | 0.03% | +28.6% |
| Q3 2019 | $36,000 | -37.9% | 840 | -41.7% | 0.02% | -36.4% |
| Q2 2019 | $58,000 | -3.3% | 1,440 | 0.0% | 0.03% | -5.7% |
| Q1 2019 | $60,000 | +17.6% | 1,440 | +7.5% | 0.04% | +12.9% |
| Q4 2018 | $51,000 | -7.3% | 1,340 | +3.5% | 0.03% | -20.5% |
| Q1 2017 | $55,000 | – | 1,295 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |